Literature DB >> 17493471

Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).

Herman A Taylor1, Alan D Penman, Hui Han, Abiola Dele-Michael, Thomas N Skelton, Ervin R Fox, Emelia J Benjamin, Donna K Arnett, Thomas H Mosley.   

Abstract

Published studies of the prognostic value of left ventricular (LV) hypertrophy and LV geometric pattern in African-Americans were based on referred or hospitalized patients with hypertension or coronary heart disease. All-cause mortality rates and survival associated with LV geometric pattern were determined using echocardiography in a population-based sample of middle-aged and elderly African-American men and women. During the third (1993 to 1995) visit of the ARIC Study, echocardiography was performed at the Jackson, Mississippi, field center on the cohort of 2,445 African-Americans aged 49 to 75 years. M-Mode LV echocardiographic measurements were available for 1,722 persons. Mortality data were available through December 31, 2003. During the follow-up period (median 8.8 years, maximum 10.4), 160 deaths were identified. In men, multivariable-adjusted hazard ratios for all-cause mortality (compared with men with normal LV geometry) were 1.75 (95% confidence interval [CI] 0.71 to 4.33) in those with concentric LV hypertrophy, 0.38 (95% CI 0.08 to 1.88) in those with eccentric LV hypertrophy, and 0.79 (95% CI 0.41 to 1.54) in those with concentric remodeling. In women, multivariable-adjusted hazard ratios for all-cause mortality (compared with women with normal LV geometry) were 1.17 (95% CI 0.48 to 2.84) in those with concentric LV hypertrophy, 1.23 (95% CI 0.46 to 3.28) in those with eccentric LV hypertrophy, and 1.17 (95% CI 0.60 to 2.28) in those with concentric remodeling. In conclusion, in this population-based cohort of middle-aged and elderly African-Americans free of coronary heart disease, adjustment for baseline differences in cardiovascular disease risk factors and LV mass greatly attenuated the strength of the association between LV pattern and all-cause mortality risk in women. In men, an association between concentric LV hypertrophy and mortality risk remained.

Entities:  

Mesh:

Year:  2007        PMID: 17493471      PMCID: PMC2713720          DOI: 10.1016/j.amjcard.2006.12.065

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

2.  Prognostic implications of left ventricular hypertrophy.

Authors:  B A Vakili; P M Okin; R B Devereux
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

3.  Measurement of left ventricular wall thickness and mass by echocardiography.

Authors:  B L Troy; J Pombo; C E Rackley
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

4.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

5.  Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study.

Authors:  Thomas N Skelton; Michael E Andrew; Donna K Arnett; Cecil M Burchfiel; Robert J Garrison; Tandaw E Samdarshi; Herman A Taylor; Richard G Hutchinson
Journal:  Echocardiography       Date:  2003-02       Impact factor: 1.724

6.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

Authors:  A Ganau; R B Devereux; M J Roman; G de Simone; T G Pickering; P S Saba; P Vargiu; I Simongini; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

7.  Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study.

Authors:  Jorge R Kizer; Donna K Arnett; Jonathan N Bella; Mary Paranicas; D C Rao; Michael A Province; Albert Oberman; Dalane W Kitzman; Paul N Hopkins; Jennifer E Liu; Richard B Devereux
Journal:  Hypertension       Date:  2004-05-03       Impact factor: 10.190

8.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study.

Authors:  D D Savage; R J Garrison; W B Kannel; D Levy; S J Anderson; J Stokes; M Feinleib; W P Castelli
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

View more
  11 in total

1.  Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.

Authors:  Ervin R Fox; Tandaw E Samdarshi; Solomon K Musani; Michael J Pencina; Jung Hye Sung; Alain G Bertoni; Vanessa Xanthakis; Pelbreton C Balfour; Satya S Shreenivas; Carolyn Covington; Philip R Liebson; Daniel F Sarpong; Kenneth R Butler; Thomas H Mosley; Wayne D Rosamond; Aaron R Folsom; David M Herrington; Ramachandran S Vasan; Herman A Taylor
Journal:  JAMA Cardiol       Date:  2016-04-01       Impact factor: 14.676

2.  Heritability and genetic linkage of left ventricular mass, systolic and diastolic function in hypertensive African Americans (From the GENOA Study).

Authors:  Ervin R Fox; Kathy L Klos; Alan D Penman; George J Blair; Benjamin D Blossom; Donna Arnett; Richard B Devereux; Tandaw Samdarshi; Eric Boerwinkle; Thomas H Mosley
Journal:  Am J Hypertens       Date:  2010-05-06       Impact factor: 2.689

3.  Echocardiographic Predictors of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study.

Authors:  Suma H Konety; Ryan J Koene; Faye L Norby; Tony Wilsdon; Alvaro Alonso; David Siscovick; Nona Sotoodehnia; John Gottdiener; Ervin R Fox; Lin Y Chen; Selcuk Adabag; Aaron R Folsom
Journal:  Circ Cardiovasc Imaging       Date:  2016-08       Impact factor: 7.792

4.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

5.  Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael J Pencina; Jayashri Aragam; Thomas J Wang; Daniel Levy; Ralph B D'Agostino; Douglas S Lee; William B Kannel; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

6.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

7.  European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Int J Behav Med       Date:  2012-12

8.  Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans.

Authors:  Ervin R Fox; Solomon K Musani; Tandaw E Samdarshi; Jared K Taylor; Walter L Beard; Daniel F Sarpong; Vanessa Xanthakis; Eric E McClendon; Philip R Liebson; Thomas N Skelton; Kenneth R Butler; Thomas H Mosley; Herman Taylor; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2015-02-05       Impact factor: 5.501

9.  Evaluation of choroidal thickness via enhanced depth-imaging optical coherence tomography in patients with systemic hypertension.

Authors:  Mustafa Gök; V Levent Karabas; Ender Emre; Arzu Toruk Aksar; Mehmet S Aslan; Dilek Ural
Journal:  Indian J Ophthalmol       Date:  2015-03       Impact factor: 1.848

10.  The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects.

Authors:  Dike B Ojji; Lionel H Opie; Sandrine Lecour; Lydia Lacerda; Olusoji M Adeyemi; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2014 Sep-Oct       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.